A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
![OHE Report_Henderson et al](https://www.ohe.org/wp-content/uploads/2021/11/OHE-Report_Henderson-et-al._Multi-indication-Rare-Diseases-2-01.png)
Patient Reported Outcome Measures (PROMs) are used to evaluate health interventions, providing a measure of an individual’s health status. The EQ-5D is a PROM recommended by NICE for measuring health benefits. It considers 5 dimensions of health and can be used across various diseases.